(NYSE: DHR) Danaher's forecast annual revenue growth rate of 5.48% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Danaher's revenue in 2024 is $23,890,000,000.On average, 9 Wall Street analysts forecast DHR's revenue for 2024 to be $17,811,134,334,140, with the lowest DHR revenue forecast at $17,580,320,766,678, and the highest DHR revenue forecast at $18,085,707,176,250. On average, 8 Wall Street analysts forecast DHR's revenue for 2025 to be $19,297,052,337,232, with the lowest DHR revenue forecast at $19,205,615,587,900, and the highest DHR revenue forecast at $19,483,743,436,500.
In 2026, DHR is forecast to generate $20,717,929,107,347 in revenue, with the lowest revenue forecast at $20,670,912,926,004 and the highest revenue forecast at $20,777,233,213,745.